BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 856307)

  • 1. [Effect of kininogen on the activity of human blood serum kininogenase system].
    Datsenko VL; Iarovaia GA; Golosova NA; Lebedeva NV; Orekhovich VN
    Biokhimiia; 1977 Feb; 42(2):283-6. PubMed ID: 856307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of kininogen on the activity of the kallikreinogen-kallikrein system of human blood serum.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1977 Jul; 78(1):85-9. PubMed ID: 884851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen.
    Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP
    Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purification and enzyme study of kininogens I and II from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):248-53. PubMed ID: 1032268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seasonal fluctuations in the kallikrein-kinin system indices].
    Tokaeva LK; Tsareva TD
    Vopr Med Khim; 1979; 25(3):266-8. PubMed ID: 222069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of components of the kallikrein-kinin system in the arterial and venous blood and cerebrospinal fluid of patients with severe cranio-cerebral injuries].
    Valeev IK; Raĭzman SM; Tsibul'kin AP
    Zh Vopr Neirokhir Im N N Burdenko; 1979; (1):27-30. PubMed ID: 425774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein].
    Nartikova VF; Egorova TP; Rets EV; Paskhina TS
    Biokhimiia; 1986 Mar; 51(3):463-71. PubMed ID: 3634630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
    Imamura T; Dubin A; Moore W; Tanaka R; Travis J
    Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purification and properties of high-molecular-weight rabbit kininogen].
    Egorova TP; Rossinskaia EB; Paskhina TS
    Biokhimiia; 1976 Jul; 41(6):1052-60. PubMed ID: 1027487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of kininogenesis indices].
    Surovikina MS; Maslikova GV; Fomina EE
    Biull Eksp Biol Med; 1983 May; 95(5):106-9. PubMed ID: 6552200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor.
    Silverberg M; Longo J; Kaplan AP
    J Biol Chem; 1986 Nov; 261(32):14965-8. PubMed ID: 3639874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
    Olson ST; Francis AM; Sheffer R; Choay J
    Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surfaces on fluid-phase prekallikrein activation.
    Scott CF; Kirby EP; Schick PK; Colman RW
    Blood; 1981 Mar; 57(3):553-60. PubMed ID: 6906235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of human low molecular weight kininogen and its application for a simple ND sensitive method for determination of human urinary kallikrein activity.
    Nakagawa M; Shimamoto K; Kondo M; Ura N; Nishitani T; Ishida H; Yokoyama T; Tanaka S; Iimura O
    Adv Exp Med Biol; 1986; 198 Pt B():523-9. PubMed ID: 3643739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of the blood kinin system in the pathogenesis of the hemorrhagic syndrome in hemorrhagic vasculitis].
    Bleian GT; Pogosian AS; Stepanian MA; Osipova EN
    Vopr Med Khim; 1978; 24(6):779-81. PubMed ID: 734977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [State of the kinin system in burn shock and early toxemia].
    Paskhina TS; Nartikova VF; Dotsenko VL; Maslova TM; Morozova NA
    Vopr Med Khim; 1976; 22(5):696-707. PubMed ID: 1014484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.